Keyword: University of Cambridge
Wren Therapeutics will use the series A round to advance its research into drugs to treat protein-misfolding diseases such as Alzheimer’s.
U.K.-based startup Fluidic Analytics reels in $31 million in a round of fundraising.
Two new studies show that CRISPR editing could raise the risk of edited cells developing tumors.
Scientists at the University of Cambridge have shown in animal models that reprogramming patients’ own skin cells may be an effective way to treat MS.
The latest biotech discoveries include a role for CDK inhibition in bone cancer and a gene involved in heart defects.
A University of Cambridge team used computer-designed antibodies to stop amyloid-beta plaques, a hallmark of Alzheimer's disease, from forming.
Research from the University of Cambridge now offers clues as to how this protein might behave in a healthy brain, hinting at new avenues for treatment.
The venture capital wings of Merck KGaA and Pfizer have contributed to a £12 million Series A investment in cancer biotech Storm Therapeutics.